| NCT07188844 | An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | ENROLLING_BY_INVITATION | PHASE2 | 2025-08-28 | 2028-11 | 2028-11 |
| NCT06979531 | Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity | RECRUITING | PHASE2 | 2025-06-30 | 2028-07 | 2028-07 |
| NCT07018323 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease | RECRUITING | PHASE2 | 2025-06-19 | 2027-05 | 2027-05 |
| NCT07039916 | Study to Access the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis | RECRUITING | PHASE3 | 2025-05-27 | 2027-12 | 2027-12 |
| NCT07032662 | IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | RECRUITING | PHASE2 | 2025-03-18 | 2030-05 | 2028-08 |
| NCT06980805 | A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) | RECRUITING | PHASE2 | 2025-02-19 | 2027-04 | 2027-04 |
| NCT06754462 | A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis | RECRUITING | PHASE2 | 2025-01-10 | 2027-09 | 2027-09 |
| NCT06727604 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease | RECRUITING | PHASE2 | 2024-12-17 | 2028-06 | 2028-06 |
| NCT05907668 | A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-05-15 | 2025-07 | 2025-07 |
| NCT05524571 | Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-01-05 | 2025-12 | 2025-12 |
| NCT05581199 | To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-12-15 | 2027-01 | 2026-01 |
| NCT05517421 | Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-11-23 | 2025-12 | 2025-12 |
| NCT05517447 | Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease | RECRUITING | PHASE3 | 2022-11-06 | 2026-08 | 2026-08 |
| NCT05403541 | Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-06-27 | 2025-04 | 2025-03 |
| NCT04253236 | To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). | TERMINATED | PHASE2 | 2020-08-11 | 2021-04-01 | 2021-04-01 |
| NCT03938545 | ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) | TERMINATED | PHASE2 | 2019-07-23 | 2021-04-15 | 2021-02-02 |
| NCT03863080 | A Study of RVT-1401 in Myasthenia Gravis (MG) Patients | COMPLETED | PHASE2 | 2019-05-21 | 2020-12-21 | 2020-10-07 |
| NCT03922321 | Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) | COMPLETED | PHASE2 | 2019-04-22 | 2020-05-21 | 2020-02-29 |